VTEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
VTEX is not a good buy right now for an impatient investor. The trend is still bearish (downtrend across moving averages with weakening momentum), and there are no Intellectia buy signals (no AI Stock Picker, no SwingMax). While the stock is near support and short-term oversold conditions could spark a bounce, the current setup is lower-probability and doesn’t justify an immediate long entry versus waiting for confirmation.
Price closed at 3.19 (down -3.09% regular session) and is sitting just above S1 support (3.169), with the next support at S2 (3.096). Trend remains bearish: SMA_200 > SMA_20 > SMA_5 confirms a persistent downtrend. MACD histogram (-0.00915) is below zero and negatively expanding, indicating downside momentum is still building rather than stabilizing. RSI_6 at ~21.7 signals oversold/washed-out conditions (despite the provided text calling it neutral), which can create short bounces, but oversold alone is not a reliable buy trigger in a strong downtrend. Key levels: upside resistance starts at the pivot 3.287 then R1 3.406; failure to reclaim ~3.29 keeps the bias bearish. Pattern-based forward stats also lean negative (1W -0.61%, 1M -4.92% expected drift).
on 2026-02-26 after hours could act as an event catalyst if results/guide surprise positively.
Primary issue is technical: the stock is in a confirmed downtrend with worsening MACD momentum, so catching a bounce is lower quality without a reversal signal. Analyst commentary flags deteriorating short-term outlook (notably Argentina exposure), which can keep pressure on near-term expectations. No supportive near-term news flow in the past week, and hedge fund/insider activity is neutral (no confidence signal). Pattern-based outlook also tilts negative over the next month.
Latest quarter (2025/Q3): Revenue 59.61M (+6.45% YoY) indicates modest growth. Profitability improved sharply: net income 6.351M (+95.72% YoY) and EPS 0.03 (+50% YoY). Gross margin expanded to 77.31% (+3.77% YoY), a constructive sign for operating leverage. Fundamentals are improving, but the market is not rewarding it yet in price action.
Recent analyst change: On 2025-11-10, JPMorgan cut the price target to $5 from $6 while maintaining Neutral, citing a deterioration in the short-term outlook (mostly Argentina). Wall Street pros view (from the provided data): Pros—improving profitability and high gross margins; Cons—near-term macro/regional risk and reduced visibility leading to a lowered target and neutral stance. Overall, the analyst stance is cautious rather than supportive of an immediate buy.
